Study of Milk Consumption in Metabolic Syndrome
This study is looking at how different types of diets, specifically those with full-fat or low-fat foods, affect adults with metabolic syndrome. Metabolic syndrome is a group of risk factors that increase your chance of heart disease, stroke, and diabetes. Researchers want to see how these diets impact your heart health and other metabolic factors. You might be able to join if you are between 18 and 70 years old and have at least three specific risk factors for metabolic syndrome, such as high blood sugar, low "good" cholesterol (HDL-C), high triglycerides, or a large waist circumference. The study will measure changes in your total cholesterol, HDL-C, and LDL-C ("bad" cholesterol) over about eight weeks to see if the diets make a difference. The study plans to enroll 40 participants, but its current status is unclear.
- Study design
- This interventional study will involve 40 participants. It compares two different diets: a full-fat diet and a low-fat diet.
- What's involved
- You would follow either a full-fat or low-fat diet for three weeks. Your cholesterol levels will be measured at the beginning, after three weeks, after five weeks, and after eight weeks.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your cholesterol levels will be monitored for eight weeks after the start of the study.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Study Of Milk Consumption In Metabolic Syndrome
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Joshua Smith, PhD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Change in Total CholesterolBaseline, Week 3, Week 5, Week 8
Total Cholesterol will be measured by a blood sample and reported as mg/dL
- Change in HDL-C (High Density Lipoprotein Cholesterol)Baseline, Week 3, Week 5, Week 8
High Density Lipoprotein Cholesterol will be measured by a blood sample and reported as mg/dL
- Change in LDL-C (Low Density Lipoprotein Cholesterol)Baseline, Week 3, Week 5, Week 8
Low Density Lipoprotein Cholesterol will be measured by a blood sample and reported as mg/dL
- Change in TriglyceridesBaseline, Week 3, Week 5, Week 8
Triglycerides will be measured by a blood sample and reported as mg/dL
- Change in Blood GlucoseBaseline, Week 3, Week 5, Week 8
Blood Glucose will be measured by a blood sample and reported as mg/dL
- Change in Hemoglobin A1cBaseline, Week 3, Week 5, Week 8
Hemoglobin is a protein within red blood cells. As glucose enters the bloodstream, it binds to hemoglobin, or glycates. The more glucose that enters the bloodstream, the higher the amount of glycated hemoglobin. An A1C level below 5.7 percent is considered normal. Reported as percentage of glycated hemoglobin.
- Change in C-reactive proteinBaseline, Week 3, Week 5, Week 8
C-reactive protein will be measured by a blood sample and reported as mg/L
- Change in LipoproteinBaseline, Week 3, Week 5, Week 8
Lipoprotein will be measured by a blood sample and reported as mg/dL
- Change in Macrovascular FunctionBaseline, Week 3, Week 5, Week 8
Peripheral macrovascular function is the maximal percent change in brachial artery following cuff release and will be assessed via flow-mediated dilation and reported as a percentage
- Change in Microvascular FunctionBaseline, Week 3, Week 5, Week 8
Quantification of the area under the curve of the brachial artery blood flow following cuff release